Avita Medical Inc (RCEL) returns
Avita Medical returns over 5 years
$1,000 invested in Avita Medical five years ago was worth $950.21 at the close on October 30, 2026, with dividends reinvested: an average return of -1.0% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +33.4% | — | $1,334 | -0.9% |
| 3 months | +248.6% | — | $3,486 | +2.1% |
| Year to date | +353.6% | — | $4,536 | +11.7% |
| 1 year | +326.4% | — | $4,264 | +12.4% |
| 3 years | +67.0% | +18.6% | $1,670 | +88.5% |
| 5 years | -5.0% | -1.0% | $950.21 | +76.0% |
Avita Medical return by calendar year
| Year | RCEL | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +353.6% | +11.7% | +341.9% |
| 2025 | -73.0% | +17.7% | -90.8% |
| 2024 | -6.7% | +24.9% | -31.6% |
| 2023 | +107.9% | +26.2% | +81.7% |
| 2022 | -44.9% | -18.2% | -26.7% |
| 2021 | -35.5% | +28.7% | -64.3% |
| 2020 | -59.2% | +18.4% | -77.5% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: RCEL financials
No forecast, no recommendation. This page describes Avita Medical Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.